Literature DB >> 6547042

Actin affinity chromatography in the purification of human, avian and other mammalian plasma proteins binding vitamin D and its metabolites (Gc globulins).

J G Haddad, M A Kowalski, J W Sanger.   

Abstract

The human plasma protein binding vitamin D and its metabolites (Gc globulin; group-specific component) has been isolated from human plasma by column affinity chromatography on gels to which monomeric actin was covalently attached. Rabbit skeletal-muscle G-actin was covalently coupled to amino-agarose gels before the application of human plasma. At actin/protein molar ratios of 4-8:1, excellent recovery (approximately 58%) of purified binding protein was achieved. After 0.75 M-NaCl washes, the binding protein was eluted from the columns in 3 M-guanidinium chloride, dialysed and analysed. These eluates contained the binding protein as 34-100% of the total protein, reflecting a 130-fold average purification in this single step. In the presence of Ca2+, gelsolin (another plasma protein that binds actin) was apparently retained by the affinity column, but this was prevented by chelation of plasma Ca2+. The actin affinity step also was effective in the isolation of the binding protein from rat, rabbit and chicken plasma, as indicated by autoradiographs of purified fractions analysed by gel electrophoresis after incubation with 25-hydroxy[26,27-3H]cholecalciferol. Further isolation by hydroxyapatite chromatography yielded a purified binding protein which displayed characteristic binding activity toward vitamin D metabolites and G-actin, and retained its physicochemical features. This brief purification sequence is relatively simple and efficient, and should prove to be useful to investigators studying this interesting plasma protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6547042      PMCID: PMC1153408          DOI: 10.1042/bj2180805

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  26 in total

1.  F-Actin-depolymerizing activity of human serum.

Authors:  R Norberg; R Thorstensson; G Utter; A Fagraeus
Journal:  Eur J Biochem       Date:  1979-10-15

2.  Human serum binding protein for vitamin D and its metabolites. II. Specific, high affinity association with a protein in nucleated tissue.

Authors:  N E Cooke; J Walgate; J G Haddad
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

Review 3.  Actin polymerization and its regulation by proteins from nonmuscle cells.

Authors:  E D Korn
Journal:  Physiol Rev       Date:  1982-04       Impact factor: 37.312

4.  An actin depolymerizing protein from pig plasma.

Authors:  H E Harris; J Gooch
Journal:  FEBS Lett       Date:  1981-01-12       Impact factor: 4.124

5.  Effects of protein modification procedures on the interaction between 25-hydroxyvitamin D and the human plasma binding protein for vitamin D and its metabolites.

Authors:  M Kawakami; D S Goodman
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

6.  Purification, characterization, and quantitation of the human serum binding protein for vitamin D and its metabolites.

Authors:  J G Haddad
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  25OHD, a circulating vitamin D metabolite in fish.

Authors:  T H Nahm; S W Lee; A Fausto; Y Sonn; L V Avioli
Journal:  Biochem Biophys Res Commun       Date:  1979-07-27       Impact factor: 3.575

8.  The isolation and characterization of the 25-hydroxyvitamin D-binding protein from chick serum.

Authors:  R Bouillon; H Van Baelen; B K Tan; P De Moor
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

9.  Vitamin D-binding protein (Gc-globulin) binds actin.

Authors:  H Van Baelen; R Bouillon; P De Moor
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

10.  Vitamin D plasma binding protein. Turnover and fate in the rabbit.

Authors:  J G Haddad; D R Fraser; D E Lawson
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  8 in total

1.  Disruption of microfilament organization in living nonmuscle cells by microinjection of plasma vitamin D-binding protein or DNase I.

Authors:  J M Sanger; G Dabiri; B Mittal; M A Kowalski; J G Haddad; J W Sanger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

2.  Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

Authors:  S E Lind; D B Smith; P A Janmey; T P Stossel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Angiopathic consequences of saturating the plasma scavenger system for actin.

Authors:  J G Haddad; K D Harper; M Guoth; G G Pietra; J W Sanger
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

4.  A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc).

Authors:  R Hoffmann; A Braun; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

5.  Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells.

Authors:  N Yamamoto; S Homma; J G Haddad; M A Kowalski
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

6.  Chromatofocusing in the purification and separation of apo- and holo-(vitamin D-binding protein).

Authors:  M J Keenan; R P Holmes
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

7.  Vitamin D binding protein sequesters monomeric actin in the circulation of the rat.

Authors:  K D Harper; J F McLeod; M A Kowalski; J G Haddad
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

8.  Analysis of the Biological Properties of Blood Plasma Protein with GcMAF Functional Activity.

Authors:  Evgeniya V Dolgova; Svetlana S Kirikovich; Evgeniy V Levites; Vera S Ruzanova; Anastasia S Proskurina; Genrikh S Ritter; Oleg S Taranov; Nikolay A Varaksin; Tatiana G Ryabicheva; Olga Yu Leplina; Alexandr A Ostanin; Elena R Chernykh; Sergey S Bogachev
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.